Wednesday’s Midday Movers: EKSO BIONICS (EKSO), Medical Marijuana Inc (MJNA), ImmunoCellular Therapeutics (IMUC), Can-Fite BioPharma (CANF), Whiting Petroleum Corp (WLL)

By Carrie Williams

So far Wednesday, May 22, NASDAQ is down -0.03% and the S&P is down -0.08%. Here are this morning’s most active stocks: EKSO BIONICS (EKSOResearch Report), Medical Marijuana Inc (MJNAResearch Report), ImmunoCellular Therapeutics (IMUCResearch Report), Can-Fite BioPharma (CANFResearch Report) and Whiting Petroleum Corp (WLLResearch Report).

EKSO BIONICS is up 13.71% in midday trading to $1.41. Shares opened today at $1.24. The company has a 52-week low of $1.18 and a 52-week high of $0.00.

Medical Marijuana Inc is up 9.38% in midday trading to $0.07. Shares opened today at $0.06. The company has a 52-week low of $0.04 and a 52-week high of $0.00.

ImmunoCellular Therapeutics is up 9.14% in midday trading to $0.02. Shares opened today at $0.02. The company has a 52-week low of $0.01 and a 52-week high of $0.00.

See today’s analyst top recommended stocks >>

Can-Fite BioPharma is down -8.97% in midday trading to $3.14. Shares opened today at $3.45. The company has a 52-week low of $2.91 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $30.00, marking a 769.57% potential upside from current levels. In a report issued on May 9, H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on CANF, with a price target of $30, which represents a potential upside of 770% from where the stock is currently trading.

See today’s analyst top recommended stocks >>

Whiting Petroleum Corp is down -8.59% in midday trading to $21.03. Shares opened today at $23.00. The company has a 52-week low of $18.37 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $36.14, marking a 57.13% potential upside from current levels. In a report released yesterday, KeyBanc analyst Leo Mariani reiterated a Buy rating on WLL, with a price target of $35, which implies an upside of 52% from current levels. Separately, on May 8, Morgan Stanley’s Drew Venker maintained a Hold rating on the stock and has a price target of $28. Over the last 3 months, the insider sentiment on Whiting Petroleum Corp has been negative based on 37 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

Trending Stocks Based on Insider Activity >>